Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Congenital chromosomal disease
|
47 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Exfoliation Syndrome
|
74 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Glaucoma
|
198 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hemorrhagic Fever, Crimean
|
9 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1 | 2019 | 2019 | |||||
Hyperlipoproteinemia Type IIa
|
661 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Osteoarthritis, Knee
|
150 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Psoriasis
|
705 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Stomach Carcinoma
|
652 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Blood Protein Measurement
|
2575 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Diabetic macroangiopathy
|
2 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Disease of capillaries
|
5 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Endometrial Carcinoma
|
326 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of endometrium
|
197 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1 | 2018 | 2018 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.020 | 0.500 | 2 | 2017 | 2019 | ||||
Ankylosing spondylitis
|
609 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1 | 2017 | 2017 | |||||
Antiphospholipid Syndrome
|
17 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Diabetic dyslipidaemia
|
11 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1 | 2017 | 2017 | |||||
Diabetic Nephropathy
|
238 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Polyendocrinopathies, Autoimmune
|
21 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1 | 2017 | 2017 | |||||
Cardiomyopathies
|
294 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Hyperhomocysteinemia
|
45 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Lupus anticoagulant disorder
|
14 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
ST segment elevation myocardial infarction
|
16 | 0.485 | 0.840 | 7 | 95308134 | missense variant | T/C | snv | 0.38 | 0.42 | 0.010 | 1.000 | 1 | 2016 | 2016 |